Design and Implement an Effective Stability Program to Support Marketed Products and Maintain Compliance to the Latest FDA, ICH and WHO Regulatory Requirements

Live, Interactive Training Webinar

Date: Wednesday December 13, 2023

Time: 10:30 am - 12:30 pm ET (New York Time)

Instructor: Kim Huynh-Ba Biography>>>

Registration Form ►

Stability is a critical quality attribute of pharmaceutical products. Stability program is necessary beyond registration to continue to support marketed products after product launch. It is challenging to design and implement an effective stability program to provide consistencies and effectively evaluate control strategies to maintain the product quality.

This comprehensive live training webinar will discuss specific activities to support the stability program, maintain consistency, support changes, provide data for product investigations and how continue to improve the process throughout the lifecycle of the product. We will also discuss deficiencies for compliance violations of marketed products and latest FDA, ICH and WHO regulatory requirements.

Learning Benefits:

  • Understand the role of the stability program supporting marketed products.
  • Understand the latest FDA, ICH and WHO regulatory requirements.
  • Develop standard stability protocols to provide consistency.
  • Develop product understanding to manage changes.
  • Establish control strategies to support manufacturing and distribution.
  • Analytical procedures considerations to maintain efficiencies.
  • Review deficiencies in the stability program and sustain global compliance.

Webinar outline and time breakdown:

Time*

10:15 AM Log-In Period

10:30 AM Introduction

                Understand the role of the stability program supporting marketed products,
Develop standard stability protocols to provide consistency,
Lifecycle approach for method validation,
Develop product understanding to manage changes,

11:30 AM 10 Minute Break

                Understand specificity requirements based on Q2A&B,
Establish control strategies to support manufacturing and distribution,
Analytical procedures considerations to maintain efficiencies,
Review deficiencies in the stability program and sustain global compliance,

12:30 PMLive Questions & Discussion

*Please note all times are Eastern Time (New York Time)

This live training webinar includes the following for each registered attendee:

  • A copy of the presentation slides
  • A certificate of training for attendee training records

Who should attend:

The following individuals or disciplines will benefit from attending this Webinar:

  • Quality Control
  • Quality Assurance
  • Analysts and Laboratory Managers
  • Regulatory Affairs Professionals
  • Pharmaceutical Scientists
  • Compliance Scientists
  • Manufacturers of raw material and ingredients

How to Attend:
All Pharma Webinars live training programs audio and visuals are delivered via Cisco WebEx with a basic system requirement of a computer with internet access. You do not require a Webex account to join Pharma Webinars’ live training courses, participants receive an email invitation that provides the access you need to join the meeting.

Instructor: Kim Huynh-Ba

Kim has almost 25 years of experience in analytical development, project management, strategic drug development and stability sciences. Prior to Pharmalytik, she held technical positions in drug development at AstraZeneca (formerly ICI Americas), DuPont Merck, DuPont Pharmaceuticals, Bristol Myers Squibb and Wyeth Vaccines. Her experiences range from analytical development to supporting CMC activities of multiple regulatory submissions, addressing regulatory responses to observations or investigations, or developing stability submission strategies.

She is an Adjunct Professor at Temple University-School of Pharmacy, Illinois Institute of Technology and Widener University. Kim currently is a member of United States Pharmacopeia (USP) General Chapter Expert Committee (2010-2015) and USP’s Reference Standard Project Team (2009-2010). She is also a member of the CHPA’s Impurities Breakout Group. She is chair of AAPS APQ Distance Learning and organized several APQ Open Forums. She serves on the Executive Committee of Governing Board of Eastern Analytical Symposium (EAS). She is the editor of the “Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices” published in 11/2008, and also “Pharmaceutical Stability Testing to Support Global Markets” published in 01/2010… Full Bio>>>